acamprosate calcium 333 MG Delayed Release Oral Tablet
RxNorm concept 835726, clinical drug (scd).
- RxCUI
- 835726
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/835726 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
acamprosate calcium 333 MG (acamprosate 300 MG) Delayed Release Oral Tablet
Related concepts
- acamprosate calcium 333 MG (SCDC, consists of)
- Delayed Release Oral Tablet (DF, has dose form)
Linked data
NDCs
- 00378633380
- 00615856039
- 00615866039
- 00904721304
- 10135063632
- 60687012125
- 60687012195
- 68382056901
- 68382056905
- 68382056906
- 68382056910
- 68382056916
- 68382056928
- 68462043511
- 68462043518
- 69452035325
- 70069086018
- 70069086030
- 70518461600
- 70518461601
- 70771105700
- 70771105701
- 70771105703
- 70771105705
- 70771105708
- 70771105709
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 835726 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/835726 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 835726. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.